Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Halozyme Therapeutics Inc (NASDAQ:HALO)

13.51
BATS BZX Real-Time Price
As of 2:30pm ET
 +0.02 / +0.15%
Today’s Change
7.70
Today|||52-Week Range
15.20
+36.74%
Year-to-Date
Slowly but Surely, Post-Fed Euphoria Dissipates
Mar 16 / TheStreet.com - Paid Partner Content
 

Today’s Trading

Previous close13.49
Today’s open13.51
Day’s range13.37 - 13.77
Volume32,594
Average volume (3 months)1,842,958
Market cap$1.8B
Dividend yield--
Data as of 2:30pm ET, 03/23/2017

Growth & Valuation

Earnings growth (last year)-224.00%
Earnings growth (this year)-19.93%
Earnings growth (next 5 years)+7.12%
Revenue growth (last year)+8.61%
P/E ratioNM
Price/Sales8.62
Price/Book--

Competitors

 Today’s
change
Today’s
% change
ONCESpark Therapeutics I...+0.10+0.19%
RDUSRadius Health Inc+0.67+1.82%
AVXSAveXis Inc+0.52+0.72%
BPMCBlueprint Medicines ...+0.13+0.32%
Data as of 2:32pm ET, 03/23/2017

Financials

Next reporting dateMay 8, 2017
EPS forecast (this quarter)-$0.25
Annual revenue (last year)$146.7M
Annual profit (last year)-$103.0M
Net profit margin-70.23%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
--, --

Forecasts


Search for Jobs